Insider · CIK 0001588365
Ezio Bonvini
Files at MGNX (MACROGENICS INC). First filing Dec 21, 2023, latest Feb 7, 2024.
In brief
Ezio Bonvini files SEC Form 4 as officer at MGNX (MACROGENICS INC). Since Dec 21, 2023, Ezio Bonvini has reported 0 open-market buys worth $0 and 4 open-market sells worth $610k, the latest filed on Feb 7, 2024.
A track record needs three past buys with six months of prices behind them; Ezio Bonvini has 0, so none is measured yet.
The newest scored trade: sold $60k of MGNX on Feb 7, 2024, filed Feb 7, 2024, scored 2 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MGNX: MACROGENICS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 2Weak | MACROGENICS INC | $60k 3,334 shares | -4% | +289% from low0% from high | |
| 12Weak | MACROGENICS INC | $200k 13,316 shares | -15% | +241% from low0% from high | |
| 11Weak | MACROGENICS INC | $160k 13,316 shares | -13% | +168% from low0% from high | |
| 12Weak | MACROGENICS INC | $190k 18,880 shares | -16% | +119% from low0% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 7, 2024 | MGNX MACROGENICS INC | 3,334 0.01% of outstanding | $60k | Feb 7, 2024 | $550k |
| Feb 1, 2024 | MGNX MACROGENICS INC | 13,316 0.02% of outstanding | $200k | Feb 1, 2024 | $350k |
| Jan 19, 2024 | MGNX MACROGENICS INC | 13,316 0.02% of outstanding | $160k | Jan 19, 2024 | $190k |
| Dec 20, 2023 | MGNX MACROGENICS INC | 18,880 0.03% of outstanding | $190k | Dec 20, 2023 | none |
Transactions
Every row this insider has filed, 34 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | MGNX MACROGENICS INC | MOption exercise Common Stock | +8,000 | $2.60 | $21k | 193,799 | 6 d ago |
| Oct 6, 2026 | MGNX MACROGENICS INC | MOption exercise Employee Stock Option (right to buy)derivative | -8,000 | $2.60 | $21k | 80,000 | 6 d ago |
| Aug 17, 2026 | MGNX MACROGENICS INC | MOption exercise Common Stock | +40,000 | $2.60 | $104k | 185,799 | Aug 18, 2026 |
| Aug 17, 2026 | MGNX MACROGENICS INC | MOption exercise Employee Stock Option (right to buy)derivative | -40,000 | $2.60 | $104k | 88,000 | Aug 18, 2026 |
| Feb 15, 2026 | MGNX MACROGENICS INC | MOption exercise Common Stock | +16,665 | - | - | 152,232 | Feb 17, 2026 |
| Feb 15, 2026 | MGNX MACROGENICS INC | FTax withholding Common Stock | -6,433 | $1.71 | $11k | 145,799 | Feb 17, 2026 |
| Feb 15, 2026 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -16,665 | $0.00 | $0 | 0 | Feb 17, 2026 |
| Feb 12, 2026 | MGNX MACROGENICS INC | AGrant or award Restricted Stock Unitderivative | +31,250 | $0.00 | $0 | 31,250 | Feb 17, 2026 |
| Feb 12, 2026 | MGNX MACROGENICS INC | AGrant or award Employee Stock Option (right to buy)derivative | +187,500 | $0.00 | $0 | 187,500 | Feb 17, 2026 |
| Feb 7, 2026 | MGNX MACROGENICS INC | MOption exercise Common Stock | +7,001 | - | - | 131,415 | Feb 10, 2026 |
| Feb 7, 2026 | MGNX MACROGENICS INC | FTax withholding Common Stock | -2,703 | $1.81 | $4,892 | 128,712 | Feb 10, 2026 |
| Feb 8, 2026 | MGNX MACROGENICS INC | MOption exercise Common Stock | +11,166 | - | - | 139,878 | Feb 10, 2026 |
| Feb 8, 2026 | MGNX MACROGENICS INC | FTax withholding Common Stock | -4,311 | $1.81 | $7,803 | 135,567 | Feb 10, 2026 |
| Feb 7, 2026 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -7,001 | $0.00 | $0 | 13,999 | Feb 10, 2026 |
| Feb 8, 2026 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -11,166 | $0.00 | $0 | 11,166 | Feb 10, 2026 |
| Feb 15, 2025 | MGNX MACROGENICS INC | MOption exercise Common Stock | +16,665 | $0.00 | $0 | 124,414 | Feb 19, 2025 |
| Feb 15, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -16,665 | $0.00 | $0 | 16,665 | Feb 19, 2025 |
| Feb 8, 2025 | MGNX MACROGENICS INC | MOption exercise Common Stock | +11,168 | - | - | 112,060 | Feb 11, 2025 |
| Feb 8, 2025 | MGNX MACROGENICS INC | FTax withholding Common Stock | -4,311 | $2.60 | $11k | 107,749 | Feb 11, 2025 |
| Feb 7, 2025 | MGNX MACROGENICS INC | AGrant or award Employee Stock Option (right to buy)derivative | +128,000 | $0.00 | $0 | 128,000 | Feb 11, 2025 |
| Feb 7, 2025 | MGNX MACROGENICS INC | AGrant or award Restricted Stock Unitderivative | +21,000 | $0.00 | $0 | 21,000 | Feb 11, 2025 |
| Feb 8, 2025 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -11,168 | $0.00 | $0 | 22,332 | Feb 11, 2025 |
| Feb 22, 2024 | MGNX MACROGENICS INC | MOption exercise Common Stock | +28,125 | $0.00 | $0 | 110,258 | Feb 26, 2024 |
| Feb 22, 2024 | MGNX MACROGENICS INC | FTax withholding Common Stock | -9,366 | $17.11 | $160k | 100,892 | Feb 26, 2024 |
| Feb 22, 2024 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -28,125 | $0.00 | $0 | 0 | Feb 26, 2024 |
| Feb 15, 2024 | MGNX MACROGENICS INC | MOption exercise Common Stock | +16,670 | $0.00 | $0 | 88,004 | Feb 20, 2024 |
| Feb 15, 2024 | MGNX MACROGENICS INC | FTax withholding Common Stock | -5,871 | $17.40 | $102k | 82,133 | Feb 20, 2024 |
| Feb 15, 2024 | MGNX MACROGENICS INC | MOption exercise Restricted Stock Unitderivative | -16,670 | $0.00 | $0 | 33,330 | Feb 20, 2024 |
| Feb 8, 2024 | MGNX MACROGENICS INC | AGrant or award Employee Stock Option (right to buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Feb 12, 2024 |
| Feb 8, 2024 | MGNX MACROGENICS INC | AGrant or award Restricted Stock Unitderivative | +33,500 | $0.00 | $0 | 33,500 | Feb 12, 2024 |
| Feb 7, 2024 | MGNX MACROGENICS INC | SOpen-market sale Common Stock10b5-1 | -3,334 | $18.00 | $60k | 71,334 | Feb 7, 2024 |
| Feb 1, 2024 | MGNX MACROGENICS INC | SOpen-market sale Common Stock10b5-1 | -13,316 | $15.00 | $200k | 74,668 | Feb 2, 2024 |
| Jan 19, 2024 | MGNX MACROGENICS INC | SOpen-market sale Common Stock10b5-1 | -13,316 | $12.00 | $160k | 87,984 | Jan 22, 2024 |
| Dec 20, 2023 | MGNX MACROGENICS INC | SOpen-market sale Common Stock10b5-1 | -18,880 | $10.08 | $190k | 101,300 | Dec 21, 2023 |
Questions about Ezio Bonvini
Answered from the filings on this page, as of the latest one.
Is Ezio Bonvini buying or selling?
Not in the last 12 months. Ezio Bonvini's latest open-market trade on SEC Form 4 was sold $60k of MGNX on Feb 7, 2024.
How did Ezio Bonvini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ezio Bonvini has 0.
Where does Ezio Bonvini file Form 4?
Ezio Bonvini has filed Form 4 at MGNX (MACROGENICS INC) as Sr VP, Research & CSO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.